Pre-FRONTal Brain STability, Key for Action Against Disability in AGing (FRONT STAGE)
Primary Purpose
Cognitive Impairment, Motoric Cognitive Risk Syndrome
Status
Unknown status
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Physical exercise (PE)
Transcranial current stimulation (tCS)
Control
Sponsored by
About this trial
This is an interventional prevention trial for Cognitive Impairment focused on measuring Older adults, Cognitive impairment, Motoric Cognitive Risk Syndrome, Physical disfunction, Multi-component physical exercise program, Transcranial electrical stimulation
Eligibility Criteria
Inclusion Criteria:
- older adults (65 years or older)
- with Motoric Cognitive Risk Syndrome
- characterized by impaired cognition (which in our case will be confirmed with a Spanish version of the Montreal cognitive Assessment (MOCA), score between 26 and 21)
- mobility impairment (measured as slow gait speed<0.8 m/s)
- without diagnosed clinical neurological or psychiatric diseases
- with a preserved functional status for the activities of daily living
- who can walk without help from third parties
Exclusion Criteria:
- a diagnosis of dementia
- advanced/terminal disease (life expectancy<1 year)
- contraindications to exercise and tCS
- unwilling to give informed consent
Sites / Locations
- The Institute of Photonic Sciences (ICFO)
- Hospital Universitario La Ribera
- Institut Català de la Salut
- Parc Sanitari Pere Virgili
- Fundació Ictus
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Active Comparator
Arm Label
Arm 1
Arm 2
Control
Arm Description
Physical exercise (PE)
Transcranial current stimulation (tCS)
Educational sessions on healthy aging
Outcomes
Primary Outcome Measures
Changes in hemoglobin oxygenation during functional tasks, as measured using fNIRS+fDCS optical techniques.
Our primary outcome will be prefrontal hemoglobin oxygenation during a) cognitive tests, such as phonetic verbal fluency and calculations (2-forward and 3-backward counting), b) normal gait, c) dual task (walking while counting).
All the measures will be controlled for extra-cerebral and systemic contributions due to variations in heart-rate, oxygen saturation, respiration rate and end-tidal carbondioxide. Various measures such as those derived from accelerometers to account for potential motion artifacts will be also utilized, followed by a multi-subject analysis.
Secondary Outcome Measures
Cognitive executive function tests - Phonetic Verbal Fluency
Phonetic verbal fluency will be measured by scoring total number of words (not repeated) per unit of time, with higher rates revealing better performance.
Rey Auditory Verbal Learning Test (RAVLT)
Rey Auditory Verbal Learning Test (RAVLT) is a validated neuropsychological test used to assess verbal memory function.
Cognitive executive function tests - SDMT
The symbol-digit modalities test (SDMT) is a symbol substitution neuropsychological test that examines a person's attention and speed of processing. Higher scores will indicate better performance.
Physical function
The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests. It has been used as a predictive tool for possible disability and can aid in the monitoring of function in older people. The scores range from 0 (worst performance) to 12 (best performance), aggregated from the different subtests.
Motor function
"Dual task" measure: cost of gait speed reduction when a cognitive task (verbal fluency) is associated during gait, compared to gait alone.
Cognitive executive function tests - Digit span
The digit span is a widely used neuropsychological test to assess attention and working memory.
Cognitive executive function tests - Trail Making Test
Trail Making Test (TMT A and B) will be perform to assess executive function (attention).
Full Information
NCT ID
NCT04115215
First Posted
September 30, 2019
Last Updated
June 30, 2021
Sponsor
Parc Sanitari Pere Virgili
Collaborators
Institute for Photonic Sciences - ICFO, Hospital de la Ribera, Fundacio Ictus Malaltia Vascular, Institut Català de la Salut, Vall d'Hebron Research Institute (sponsor)
1. Study Identification
Unique Protocol Identification Number
NCT04115215
Brief Title
Pre-FRONTal Brain STability, Key for Action Against Disability in AGing
Acronym
FRONT STAGE
Official Title
Pre-FRONTal Brain STability, Key for Action Against Disability in AGing: The FRONT STAGE Project
Study Type
Interventional
2. Study Status
Record Verification Date
June 2021
Overall Recruitment Status
Unknown status
Study Start Date
March 23, 2020 (Actual)
Primary Completion Date
March 23, 2023 (Anticipated)
Study Completion Date
March 23, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Parc Sanitari Pere Virgili
Collaborators
Institute for Photonic Sciences - ICFO, Hospital de la Ribera, Fundacio Ictus Malaltia Vascular, Institut Català de la Salut, Vall d'Hebron Research Institute (sponsor)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Cognitive and mobility impairments are critical contributors to dementia and disability in older adults, and can be caused by neurodegenerative and neurovascular changes at the pre-frontal (PF) brain areas. In a previous technological project funded by ISCiii, the investigators adapted a non-invasive, point-of-care optical methods (fNRIS/fDCS technology) to study PF metabolism and blood flow activation during cognitive and motor tasks, in older adults with and without cognitive impairment. These methods are sensitive to change after physical exercise (PE) and after selectively and safely stimulating PF areas with electrical transcranial direct current stimulation (tCS). PE and tCS have shown benefits for cognition and mobility in the elderly, but their prolonged effect on PF hemodynamic activation has not been studied. Understanding the specific action of these interventions on the brain, and their clinical cognitive and motor impact, is key to fine-tune appropriate treatment strategies.
The FRONT STAGE project aims to compare, through a 3 arms single-blind randomized clinical trial, the impact of a 10 weeks, 1 hour/week program of PE (arm 1) Vs PE+tCS (arm 2) and Vs a control group (arm 3, healthy aging sessions and control of cardiovascular risk factors). The PE program is already implemented in primary care, as part of another previous project of the investigators' research group. Outcomes will include the optical measurement of PF metabolism and blood flow and clinical measures of cognitive and physical function. Front STAGE project will recruit 93 older adults with cognitive impairment and slow gait, but without dementia or disability in the activities of daily living (N=31 per arm). They will receive a comprehensive geriatric assessment at baseline, together with the optical, cognitive and physical measures, and will be follow-up at 3 and 6 months. Weekly physical activity through accelerometry will be controlled in analyses.
FRONT STAGE project centered on aging and the prevention of dementia and disability, will provide, translationally, more evidence to support and enlarge the clinical application of these interventions, and will contribute to foster further research in this field.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cognitive Impairment, Motoric Cognitive Risk Syndrome
Keywords
Older adults, Cognitive impairment, Motoric Cognitive Risk Syndrome, Physical disfunction, Multi-component physical exercise program, Transcranial electrical stimulation
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Masking Description
The investigators performing the follow-up assessments will be blind to randomization. In light of the difficulty to guarantee a complete blinding, these investigators will record if blinding is disclosed by participants during the interview.
Allocation
Randomized
Enrollment
93 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Arm 1
Arm Type
Experimental
Arm Description
Physical exercise (PE)
Arm Title
Arm 2
Arm Type
Experimental
Arm Description
Transcranial current stimulation (tCS)
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Educational sessions on healthy aging
Intervention Type
Behavioral
Intervention Name(s)
Physical exercise (PE)
Intervention Description
This arm includes 10 sessions of multi-component exercise sessions (including aerobic, resistance, flexibility, dual-tasking) of 1 hour/week of functional group exercise, directed to foster empowerment for subsequent continuation of exercise in community-dwelling older adults referred by primary care to a geriatrician and an expert physical therapist. Participants will receive a leaflet with instructions to perform five strength-based exercises and instructors will recommend participants to perform the exercises and walk at least 15 minutes daily.
Intervention Type
Device
Intervention Name(s)
Transcranial current stimulation (tCS)
Intervention Description
This arm includes 1 application/week for 10 weeks during PE, through an adapted commercial helmet. Transcranial current stimulation (tCS) is a neural stimulation technique based on electrical stimulation of selected parts of the brain with direct or alternated electrical current (tDCS or tACS) of very low intensity of 1,5 milliamps (mA), using one or more electrodes placed on the skull. tCS is non-invasive (no surgical procedures) and it is painless, as applied in the proposed protocols.
Intervention Type
Other
Intervention Name(s)
Control
Intervention Description
Participants of similar profile, randomized to the control group, will undergo weekly 30 minutes educational sessions on healthy aging, including relevant aspects of nutrition, self-care, physical activity, plus measurement of blood pressure, heart rate and peripheral oxygen Hb saturation. These participants will be offered to join the PE program after the 6-months follow-up (end of the study).
Primary Outcome Measure Information:
Title
Changes in hemoglobin oxygenation during functional tasks, as measured using fNIRS+fDCS optical techniques.
Description
Our primary outcome will be prefrontal hemoglobin oxygenation during a) cognitive tests, such as phonetic verbal fluency and calculations (2-forward and 3-backward counting), b) normal gait, c) dual task (walking while counting).
All the measures will be controlled for extra-cerebral and systemic contributions due to variations in heart-rate, oxygen saturation, respiration rate and end-tidal carbondioxide. Various measures such as those derived from accelerometers to account for potential motion artifacts will be also utilized, followed by a multi-subject analysis.
Time Frame
Baseline (prior to intervention), 3 and 6 months after completion of the intervention.
Secondary Outcome Measure Information:
Title
Cognitive executive function tests - Phonetic Verbal Fluency
Description
Phonetic verbal fluency will be measured by scoring total number of words (not repeated) per unit of time, with higher rates revealing better performance.
Time Frame
Baseline (prior to intervention), 3 and 6 months after completion of the intervention.
Title
Rey Auditory Verbal Learning Test (RAVLT)
Description
Rey Auditory Verbal Learning Test (RAVLT) is a validated neuropsychological test used to assess verbal memory function.
Time Frame
Baseline (prior to intervention), 3 and 6 months after completion of the intervention.
Title
Cognitive executive function tests - SDMT
Description
The symbol-digit modalities test (SDMT) is a symbol substitution neuropsychological test that examines a person's attention and speed of processing. Higher scores will indicate better performance.
Time Frame
Baseline (prior to intervention), 3 and 6 months after completion of the intervention.
Title
Physical function
Description
The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests. It has been used as a predictive tool for possible disability and can aid in the monitoring of function in older people. The scores range from 0 (worst performance) to 12 (best performance), aggregated from the different subtests.
Time Frame
Baseline (prior to intervention), 3 and 6 months after completion of the intervention.
Title
Motor function
Description
"Dual task" measure: cost of gait speed reduction when a cognitive task (verbal fluency) is associated during gait, compared to gait alone.
Time Frame
Baseline (prior to intervention), 3 and 6 months after completion of the intervention.
Title
Cognitive executive function tests - Digit span
Description
The digit span is a widely used neuropsychological test to assess attention and working memory.
Time Frame
Baseline (prior to intervention), 3 and 6 months after completion of the intervention.
Title
Cognitive executive function tests - Trail Making Test
Description
Trail Making Test (TMT A and B) will be perform to assess executive function (attention).
Time Frame
Baseline (prior to intervention), 3 and 6 months after completion of the intervention.
Other Pre-specified Outcome Measures:
Title
Spatial temporal parameters of gait
Description
Step length, width and cadence; using the portable 4 meters Protokinetics Zeno computerized carpet.
Time Frame
Baseline (prior to intervention), 3 and 6 months after completion of the intervention.
Title
Total time of daily physical activity
Description
ActivPal devices will be applied for 7 consecutive days to monitor physical activity outside and between exercise sessions, and also in the control group, in order to subsequently adjust the analyses for the activity performed out of the exercise sessions.
Time Frame
7 consecutive days (arms 2 & 3) just after the start of the intervention.
Title
Clinical comorbidity
Description
The Charlson Comorbidity Index is a method of categorizing comorbidities of patients based on the International Classification of Diseases (ICD) diagnosis codes found in administrative data, such as hospital abstracts data. Each comorbidity category has an associated weight (from 1 to 6), based on the adjusted risk of mortality or resource use, and the sum of all the weights results in a single comorbidity score for a patient. A score of zero indicates that no comorbidities were found. The higher the score, the more likely the predicted outcome will result in mortality or higher resource use.
Time Frame
Baseline.
Title
Nutritional status
Description
The Mini Nutritional Assessment Short Form (MNA®-SF) is an effective tool to help identify patients who are malnourished or at risk of malnutrition. Scores range from: 12-14 points, Normal nutritional status; 8-11 points At risk of malnutrition; 0-7 points Malnourished.
Time Frame
Baseline.
Title
Demographics
Description
Age, gender, education, former profession, marital status, living situation and physical barriers, presence of a valid caregiver.
Time Frame
Baseline.
Title
Self-reported quality of life
Description
EuroQol-5D is a standardized instrument for measuring generic health status. It has been widely used in population health surveys, clinical studies, economic evaluation and in routine outcome measurement in the delivery of operational healthcare. This instrument is designed for self-completion and as such captures information directly from the respondent, thereby generating data that conforms with the general requirement of all Patient Reported Outcome (PRO) measures. Total score will be used, with higher scores revealing higher quality of life.
Time Frame
Baseline
Title
Body Mass Index
Description
Weight & Height will be collected and computed to obtain Body Mass Index.
Time Frame
Baseline
Title
Depressive symptoms
Description
The Yesavage GDS-15 items assesses depressive symptoms. The scale consists of 15 yes/no questions. Each question is scored as either 0 or 1 points. The following general cutoff may be used to qualify the severity of depressive symptoms: normal 0-4, >=5 possible depression.
Time Frame
Baseline
Title
Quality of sleep
Description
Total score of the Jenkins questionnaire will be used to estimate quality of sleep. This questionnaire consists of 4 items rated on a 6-point scale. The 4 items ask how frequently during the previous 4 weeks the respondent experienced difficulty falling asleep, difficulty staying asleep, waking up several times per night, and waking up feeling tired and worn out after the usual amount of sleep. A dichotomous index is computed and coded as 1 if the respondents reported that any of the above sleep disturbances occurred 15 or more nights during the previous 4 weeks or as 0, if not. The selection of 15 nights as the cut-off point for sleep disturbance was based on criteria from the DSM-IV-TR, which stipulate that difficulty maintaining/initiating sleep or non-restorative sleep should be present for 3 or more nights per week for at least 1 month. A similar cut-off point for sleep disturbance was used in previous studies.
Time Frame
Baseline
Title
Drugs
Description
Total number of drugs prescribed.
Time Frame
Baseline
Title
Hypertension
Description
Diagnosis of hypertension (yes / no) will be collected as a cardiovascular risk factor.
Time Frame
Baseline
Title
Cholesterol
Description
High cholesterol (yes / no) will be collected as a cardiovascular risk factor.
Time Frame
Baseline
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
older adults (65 years or older)
with Motoric Cognitive Risk Syndrome
characterized by impaired cognition (which in our case will be confirmed with a Spanish version of the Montreal cognitive Assessment (MOCA), score between 26 and 21)
mobility impairment (measured as slow gait speed<0.8 m/s)
without diagnosed clinical neurological or psychiatric diseases
with a preserved functional status for the activities of daily living
who can walk without help from third parties
Exclusion Criteria:
a diagnosis of dementia
advanced/terminal disease (life expectancy<1 year)
contraindications to exercise and tCS
unwilling to give informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marco Inzitari, PhD
Organizational Affiliation
Parc Sanitari Pere Virgili - Vall d'Hebron Institute of Research
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Institute of Photonic Sciences (ICFO)
City
Castelldefels
State/Province
Barcelona
ZIP/Postal Code
08860
Country
Spain
Facility Name
Hospital Universitario La Ribera
City
Alzira
State/Province
Valencia
ZIP/Postal Code
46600
Country
Spain
Facility Name
Institut Català de la Salut
City
Barcelona
ZIP/Postal Code
08004
Country
Spain
Facility Name
Parc Sanitari Pere Virgili
City
Barcelona
ZIP/Postal Code
08023
Country
Spain
Facility Name
Fundació Ictus
City
Barcelona
ZIP/Postal Code
08036
Country
Spain
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Pre-FRONTal Brain STability, Key for Action Against Disability in AGing
We'll reach out to this number within 24 hrs